Table of Contents
Increasing population of baby boomers is a major factor driving the consumption of clinical nutrition products. With increasing age, digestion abilities of the human digestive system decreases, thus makes it difficult for the body to absorb all the required nutrients from food. Loss of appetite is also a common problem among baby boomers. As a result, aging individuals do not get optimal amounts of nutrients. Hence, they resort to additional supplements for proper nourishment. In order to stay fit, their dependence on clinical nutrition increases. According to the Population Division of the United Nations Department of Economic and Social Affairs (UN-DESA), 841 million people were aged 60 years and above in 2013 compared to 205 million people in 1950. The population is projected to reach over 2 billion by 2050. With the increasing population of baby boomers, spending on clinical nutrition is expected to increase.
Asia-Pacific is the largest market for clinical nutritional products globally. Increasing birth rate paired with increasing geriatric population is driving the clinical nutrition market in the Asia Pacific region. Countries such as India and China have high birth rate, which is expected to boost the demand for clinical nutrition products, especially infant nutrition products. Some of the major factors contributing the growth of clinical nutrition market in North America include Increase in consumer awareness about health and wellbeing paired with increasing healthcare cost. Growing aging population coupled with high birth rate in some European countries, such as the U.K. and France, are driving the clinical nutrition market in the region.
The report covers in-depth Clinical Nutrition market analysis, by type segment (infant nutrition, enteral nutrition, and parenteral nutrition), by infant nutrition type segment (milk-based, soy-based, organic, probiotic/prebiotic, and others), and by enteral nutrition type segment (standard, and enteral nutrition for chronic illnesses) for the period 2010 to 2020. In addition, the current Clinical Nutrition market dynamics including the drivers, restraints, opportunities and recent developments have been captured throughout the report. The Competitive Landscape section of the clinical nutrition market report includes companies market share globally included in the report. The report also includes benchmarking section which provides an insight on the revenue generated and presence of its offerings in the three clinical nutrition categories: infant nutrition, enteral nutrition, and parenteral nutrition of the companies. Some of the major players in the Clinical Nutrition market are Nestlé SA, Baxter International, Inc., Abbott Laboratories, B. Braun Melsungen AG, H. J. Heinz Company, Groupe Danone, Mead Johnson Nutrition Company, Fresenius Kabi AG, Hospira, Inc. and Perrigo Company Plc.
Key points covered in the report
The report provides historic, present and forecasted market size, analysis, trend, share, and growth
The report segments the market on the basis of products type by value (USD billion) for all Geography
The report covers clinical nutrition products segmentation
The infant nutrition products segmentation
The enteral nutrition products segmentation
Enteral Nutrition for Chronic Illnesses
The report covers geographic segmentation
The report provides company profiles of some of the leading companies operating in the market
The report also provides porters five forces analysis of the market
Get Industry Insights. Simply.
Talk to Ahmad
+1 718 618 4302
This report analyzes the worldwide markets for Clinical Nutrition Products in US$ Million. The Global market is analyzed by the following segments: Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition. ...
The global enteral feeding devices market accounted for a market value of USD 1,752 million in 2015 and is expected to reach USD 1,831 million in 2016 and USD 2,285 million by 2021, growing at a CAGR of ...
The global clinical nutrition market is estimated to be USD XX million in 2016 and is expected to reach USD 51,174 million by 2021, growing at a CAGR of 4.82% during the forecast period from 2016 to 2021. ...